RxDoctor Payments Data

Jason Colinger, DO

Family Medicine · Erwin, TNNPI 1609829241

Payments from drug & device makers

$13,943in general payments, 2019–2025

Across 952 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • GSK$913
  • AstraZeneca$877
  • Boehringer Ingelheim$657
  • plus $7K from 40 others

What the payments were for

  • Food & beverage$13,85399%
  • Education$260%
  • Gifts$640%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$13,943 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$165,760
Medicare patients
424
Services billed
3,576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban683$274,613
JardianceEmpagliflozin318$223,870
NuplazidPimavanserin Tartrate68$194,739
MounjaroTirzepatide158$174,162
OzempicSemaglutide140$158,062
TrulicityDulaglutide153$152,309
FarxigaDapagliflozin Propanediol160$105,537
XifaxanRifaximin25$83,979
XareltoRivaroxaban121$67,934
RybelsusSemaglutide52$57,916
VraylarCariprazine Hcl39$50,871
Trelegy ElliptaFluticasone/Umeclidin/Vilanter63$48,998
EntrestoSacubitril/Valsartan48$46,363
NuedextaDextromethorphan Hbr/Quinidine67$44,862
Nurtec OdtRimegepant Sulfate35$36,437

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,197$326,472311 claims
PfizerEliquis, Nurtec Odt$344$311,049718 claims
Boehringer IngelheimJardiance, Synjardy$657$234,994336 claims
Novo NordiskOzempic, Rybelsus$1,775$215,978192 claims
Acadia Pharmaceuticals IncNuplazid$136$194,73968 claims
AstraZenecaFarxiga, Breztri Aerosphere$877$123,787186 claims
Johnson & JohnsonXarelto, Invega Sustenna$498$96,737132 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$54$83,97925 claims
AbbVieVraylar, Linzess, Fetzima$1,642$76,317103 claims
GSKTrelegy Ellipta, Anoro Ellipta$913$63,53281 claims
NovartisEntresto$451$46,36348 claims
Avanir Pharmaceuticals, Inc.Nuedexta$45$44,86267 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Erwin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →